+499.5%
MRNA vs HTZ
-58.1%
+557.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.3% | -3.6% | -2.4% |
| 7D | +5.5% | +7.5% | -2.0% | +4.2% |
| 30D | +158.7% | +47.4% | +111.3% | +150.6% |
| 3M | +182.1% | -54.9% | +237.0% | +193.3% |
| 6M | +151.8% | -47.0% | +198.8% | +155.8% |
| YTD | +393.6% | -55.3% | +448.8% | +407.6% |
| 1Y | +499.5% | -57.6% | +557.1% | +548.6% |
| All | +499.5% | -58.1% | +557.6% | +548.6% |
Cumulative growth
Daily Returns
Daily percentage return beside HTZ.
Daily Out/Under-Performance
Portfolio return minus HTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling